Cigna Group
CIAPI behind this page
CI FY 2025 request
Playground key active
/api/financials?ticker=CI&year=2025&quarter=4&full_year_mode=true
Pick an endpoint and run the request.Income Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Revenue (FY) | — | — | — |
Show Product Lines breakouts |
|||
| Home delivery and specialty revenues · Evernorth Health Services | 80,492 | 72,476 | +11.1% |
| Network revenues · Evernorth Health Services | 125,573 | 105,340 | +19.2% |
| Other revenues · Evernorth Health Services | 13,329 | 11,545 | +15.5% |
| Product | 216,672 | 185,362 | +16.9% |
| Product · All Other Segments | 54 | 60 | -10.0% |
| Product · Corporate and Eliminations | -2,776 | -4,059 | +31.6% |
| Product · Evernorth Health Services | 219,394 | 189,361 | +15.9% |
| Service | 16,921 | 14,790 | +14.4% |
| Service Other | 696 | 584 | +19.2% |
| Service, Fees And Other Revenues [Member] | 16,921 | 14,790 | +14.4% |
| Service, Fees And Other Revenues [Member] · All Other Segments | 34 | 79 | -57.0% |
| Service, Fees And Other Revenues [Member] · Cigna Healthcare | 7,154 | 6,988 | +2.4% |
| Service, Fees And Other Revenues [Member] · Corporate and Eliminations | -5,684 | -4,868 | -16.8% |
| Service, Fees And Other Revenues [Member] · Evernorth Health Services | 15,417 | 12,591 | +22.4% |
| Premiums Earned Net (FY) | — | — | — |
Show Product Lines breakouts |
|||
| Employer insured · Cigna Healthcare | 18,852 | 17,576 | +7.3% |
| Individual and Family Plans · Cigna Healthcare | 3,371 | 3,951 | -14.7% |
| Long-duration | 1 | 2 | -50.0% |
| Medicare Advantage · Cigna Healthcare | 2,363 | 8,679 | -72.8% |
| Other · Cigna Healthcare | 3,366 | 4,938 | -31.8% |
| Short-duration | 39.3 | 43.9 | -10.5% |
| Stop loss · Cigna Healthcare | 7,599 | 6,744 | +12.7% |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 288 | 380 | -24.2% |
| Cigna Healthcare · International Health | 4,126 | 3,624 | +13.9% |
| Cigna Healthcare · Operating Segments | 39,677 | 45,512 | -12.8% |
| Cigna Healthcare · U.S. Healthcare | 35,551 | 41,888 | -15.1% |
Show — breakouts |
|||
| Premiums Earned Net | 40,261 | 45,996 | -12.5% |
Show Consolidation Items breakouts |
|||
| Corporate and Eliminations | 296 | 104 | +184.6% |
| Net Investment Income (FY) | — | — | — |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 298 | 309 | -3.6% |
| Cigna Healthcare · Operating Segments | 581 | 618 | -6.0% |
| Evernorth Health Services · Operating Segments | 142 | 21 | +576.2% |
Show — breakouts |
|||
| Net Investment Income | 1,046 | 973 | +7.5% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 21 | 26 | -19.2% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 25 | 25 | 0.0% |
| Revenue (FY) | — | — | — |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 674 | 828 | -18.6% |
| Cigna Healthcare · Operating Segments | 47,412 | 53,118 | -10.7% |
| Evernorth Health Services · Operating Segments | 234,953 | 201,973 | +16.3% |
Show — breakouts |
|||
| Revenue | 274,900 | 247,121 | +11.2% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 490 | 495 | -1.0% |
Show Consolidation Items breakouts |
|||
| Corporate and Eliminations | -8,139 | -8,798 | +7.5% |
Show Equity Method Investment Nonconsolidated Investee breakouts |
|||
| Operating joint ventures | 7,747 | 7,309 | +6.0% |
| Cost of Revenue (FY) | — | — | — |
Show Business Segments breakouts |
|||
| Evernorth Health Services · Operating Segments | 223,086 | 190,968 | +16.8% |
Show — breakouts |
|||
| Cost of Revenue | 214,991 | 182,509 | +17.8% |
| Policyholder Benefits And Claims Incurred Net (FY) | — | — | — |
Show Business Segments breakouts |
|||
| Cigna Healthcare · Operating Segments | 33,474 | 37,887 | -11.6% |
Show — breakouts |
|||
| Policyholder Benefits And Claims Incurred Net | 34,349 | 38,648 | -11.1% |
| Selling, General & Administrative (FY) | — | — | — |
Show — breakouts |
|||
| Selling, General & Administrative | 14,617 | 14,844 | -1.5% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 5 | 14 | -64.3% |
| Amortization Of Intangible Assets (FY) | — | — | — |
Show Business Segments breakouts |
|||
| Cigna Healthcare · Operating Segments | 23 | 41 | -43.9% |
| Evernorth Health Services · Operating Segments | 1,720 | 1,662 | +3.5% |
Show — breakouts |
|||
| Amortization Of Intangible Assets | 1,743 | 1,703 | +2.3% |
| Benefits Losses And Expenses (FY) | — | — | — |
Show — breakouts |
|||
| Benefits Losses And Expenses | 265,700 | 237,704 | +11.8% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 5 | 14 | -64.3% |
| Operating Income (FY) | — | — | — |
Show — breakouts |
|||
| Operating Income | 9,200 | 9,417 | -2.3% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 485 | 481 | +0.8% |
| Other Non-Operating Income (Expense) (FY) | — | — | — |
Show Business Segments breakouts |
|||
| Cigna Healthcare · Operating Segments | 9 | 7 | +28.6% |
| Evernorth Health Services · Operating Segments | -1 | -2 | +50.0% |
Show — breakouts |
|||
| Other Non-Operating Income (Expense) | -1,408 | -1,435 | +1.9% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -1,365 | -1,388 | +1.7% |
| Gain Loss On Sale Of Business (FY) | — | — | — |
Show — breakouts |
|||
| Gain Loss On Sale Of Business | 13 | 24 | -45.8% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 4,890 | — | — |
| Net Investment Gain Loss (FY) | — | — | — |
Show — breakouts |
|||
| Net Investment Gain Loss | -24 | -2,737 | +99.1% |
| Income Before Taxes (FY) | — | — | — |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | -46 | -12 | -283.3% |
| Cigna Healthcare · Operating Segments | 4,344 | 3,315 | +31.0% |
| Evernorth Health Services · Operating Segments | 5,826 | 3,929 | +48.3% |
Show — breakouts |
|||
| Income Before Taxes | 7,781 | 5,269 | +47.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 4,010 | -909 | +541.1% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -2,343 | -1,963 | -19.4% |
| Income Tax Expense (Benefit) (FY) | — | — | — |
Show — breakouts |
|||
| Income Tax Expense (Benefit) | 1,493 | 1,491 | +0.1% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -201 | -189 | -6.3% |
| Net Income (FY) | — | — | — |
Show — breakouts |
|||
| Net Income | 6,288 | 3,778 | +66.4% |
Show Equity Method Investment Nonconsolidated Investee breakouts |
|||
| Operating joint ventures | 755 | 607 | +24.4% |
| Net Income Loss Attributable To Noncontrolling Interest (FY) | — | — | — |
Show — breakouts |
|||
| Net Income Loss Attributable To Noncontrolling Interest | 331 | 344 | -3.8% |
| Net Income (FY) | — | — | — |
Show — breakouts |
|||
| Net Income | 5,957 | 3,434 | +73.5% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 5,957 | 3,434 | +73.5% |
| EPS (Basic) (FY) | — | — | — |
Show — breakouts |
|||
| EPS (Basic) | 22.33 | 12.25 | +82.3% |
| EPS (Diluted) (FY) | — | — | — |
Show — breakouts |
|||
| EPS (Diluted) | 22.18 | 12.12 | +83.0% |
| Comprehensive Income (FY) | — | — | — |
Show — breakouts |
|||
| Comprehensive Income | 5,492 | 2,957 | +85.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 5,492 | 2,957 | +85.7% |
| Other Comprehensive Income (FY) | — | — | — |
Show Consolidated Entities breakouts |
|||
| Parent Company | -465 | -477 | +2.5% |
| Wtd Avg Shares (Diluted) (FY) | — | — | — |
Show — breakouts |
|||
| Wtd Avg Shares (Diluted) | 268,563 | 283,218 | -5.2% |
| Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 (FY) | — | — | — |
Show Business Segments breakouts |
|||
| Cigna Healthcare | 33,474 | 37,891 | -11.7% |
Balance Sheet
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents (Q) | — | — | — |
Show — breakouts |
|||
| Cash & Cash Equivalents | 7,676 | 7,550 | +1.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 118 | 164 | -28.0% |
| Short-Term Investments (Q) | — | — | — |
Show — breakouts |
|||
| Short-Term Investments | 1,056 | 665 | +58.8% |
Show Investment Type breakouts |
|||
| Debt Securities | 691 | — | — |
| Equity Securities | 22 | — | — |
| Mortgages | 86 | — | — |
| Short Term Investments | 257 | — | — |
| Receivables Net Current (Q) | — | — | — |
Show — breakouts |
|||
| Receivables Net Current | 28,768 | 24,227 | +18.7% |
| Inventory (Q) | — | — | — |
Show — breakouts |
|||
| Inventory | 7,338 | 6,692 | +9.7% |
| Other Assets Current (Q) | — | — | — |
Show — breakouts |
|||
| Other Assets Current | 2,976 | 2,732 | +8.9% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 29 | 103 | -71.8% |
| Parent Company · Evernorth Health, Inc. | 8.5 | 8.5 | 0.0% |
| Total Current Assets (Q) | — | — | — |
Show — breakouts |
|||
| Total Current Assets | 47,814 | 48,870 | -2.2% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 147 | 267 | -44.9% |
| Reinsurance Recoverables Non Current (Q) | — | — | — |
Show — breakouts |
|||
| Reinsurance Recoverables Non Current | 4,103 | 4,378 | -6.3% |
| Non-Current Assets | |||
| Long Term Investments (Q) | — | — | — |
Show — breakouts |
|||
| Long Term Investments | 18,471 | 15,128 | +22.1% |
Show Investment Type breakouts |
|||
| Debt Securities | 7,671 | — | — |
| Equity Securities | 3,534 | — | — |
| Mortgages | 1,147 | — | — |
| Other Long Term Investments | 5,037 | — | — |
| Policy Loans | 1,082 | — | — |
| Goodwill (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Cigna Healthcare | 8,942 | 8,936 | +0.1% |
| Evernorth Health Services | 35,982 | 35,434 | +1.5% |
Show — breakouts |
|||
| Goodwill | 44,924 | 44,370 | +1.2% |
| Other Non-Current Assets (Q) | — | — | — |
Show — breakouts |
|||
| Other Non-Current Assets | 2,885 | 2,786 | +3.6% |
Show Consolidated Entities breakouts |
|||
| Parent Company · Nonrelated Party | 48 | 71 | -32.4% |
| Parent Company · Subsidiaries | 14,146 | 10,546 | +34.1% |
| Total Assets (Q) | — | — | — |
Show — breakouts |
|||
| Total Assets | 157,919 | 155,881 | +1.3% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 75,723 | 73,771 | +2.6% |
Show Equity Method Investment Nonconsolidated Investee breakouts |
|||
| Operating joint ventures | 39,547 | 34,395 | +15.0% |
| Property, Plant & Equipment (Q) | — | — | — |
Show — breakouts |
|||
| Property, Plant & Equipment | 3,651 | — | — |
Show Property Plant And Equipment By Type breakouts |
|||
| Other property and equipment | 877 | — | — |
| Software And Software Development Costs | 2,774 | — | — |
| Intangible Assets (Q) | — | — | — |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Customer Relationships | 19,969 | — | — |
| Other Assets | |||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization (Q) | — | — | — |
Show — breakouts |
|||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 3,651 | 3,654 | -0.1% |
| Intangible Assets Net Excluding Goodwill (Q) | — | — | — |
Show — breakouts |
|||
| Intangible Assets Net Excluding Goodwill | 28,560 | 29,417 | -2.9% |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Other Intangible Assets | 191 | — | — |
| Separate Account Asset At Carrying Value (Q) | — | — | — |
Show — breakouts |
|||
| Separate Account Asset At Carrying Value | 7,511 | 7,278 | +3.2% |
| Current Liabilities | |||
| Insurance And Contractholder Liabilities Current (Q) | — | — | — |
Show — breakouts |
|||
| Insurance And Contractholder Liabilities Current | 5,710 | 5,388 | +6.0% |
| Accounts Payable (Q) | — | — | — |
Show — breakouts |
|||
| Accounts Payable | 10,659 | 9,294 | +14.7% |
| Debt Current (Q) | — | — | — |
Show — breakouts |
|||
| Debt Current | 592 | 3,035 | -80.5% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 550 | 2,848 | -80.7% |
| Total Current Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Total Current Liabilities | 56,342 | 57,979 | -2.8% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 2,533 | 4,376 | -42.1% |
| Current Portion of Long-Term Debt (Q) | — | — | — |
Show Debt Instrument breakouts |
|||
| 1.250% Notes due March 2026 | 549 | — | — |
| Non-Current Liabilities | |||
| Insurance And Contractholder Liabilities Noncurrent (Q) | — | — | — |
Show — breakouts |
|||
| Insurance And Contractholder Liabilities Noncurrent | 9,938 | 10,254 | -3.1% |
| Deferred Tax Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Deferred Tax Liabilities | 7,145 | 6,975 | +2.4% |
| Other Non-Current Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Other Non-Current Liabilities | 4,238 | 3,215 | +31.8% |
Show Consolidated Entities breakouts |
|||
| Parent Company · Nonrelated Party | 75 | 33 | +127.3% |
| Parent Company · Subsidiaries | 1,134 | 195 | +481.5% |
| Total Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Total Liabilities | 116,045 | 114,638 | +1.2% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 34,010 | 32,738 | +3.9% |
Show Equity Method Investment Nonconsolidated Investee breakouts |
|||
| Operating joint ventures | 40,009 | 33,892 | +18.0% |
| Long-Term Debt (Q) | — | — | — |
Show Debt Instrument breakouts |
|||
| 2.375% Notes due March 2031 | 1,420 | 1,384 | +2.6% |
| 2.400% Notes due March 2030 | 1,406 | 1,386 | +1.4% |
| 3.050% Notes due October 2027 | 599 | 598 | +0.2% |
| 3.200% Notes due March 2040 | 748 | 744 | +0.5% |
| 3.400% Notes due March 2027 | 1,481 | 1,466 | +1.0% |
| 3.400% Notes due March 2050 | 1,172 | 1,237 | -5.3% |
| 3.400% Notes due March 2051 | 1,410 | 1,479 | -4.7% |
| 3.875% Notes due October 2047 | 990 | 990 | 0.0% |
| 4.375% Notes due October 2028 | 3,792 | 3,790 | +0.1% |
| 4.500% Notes due September 2030 | 993 | — | — |
| 4.800% Notes due August 2038 | 2,194 | 2,193 | 0.0% |
| 4.800% Notes due July 2046 | 1,469 | 1,469 | 0.0% |
| 4.875% Notes due September 2032 | 1,243 | — | — |
| 4.900% Notes due December 2048 | 2,972 | 2,971 | 0.0% |
| 5.000% Notes due May 2029 | 996 | 995 | +0.1% |
| 5.125% Notes due May 2031 | 750 | 745 | +0.7% |
| 5.250% Notes due February 2034 | 1,250 | 1,226 | +2.0% |
| 5.250% Notes due January 2036 | 1,488 | — | — |
| 5.375% Notes due February 2042 | 315 | 315 | 0.0% |
| 5.400% Notes due March 2033 | 796 | 795 | +0.1% |
| 5.600% Notes due February 2054 | 1,486 | 1,482 | +0.3% |
| 5.875% Notes due March 2041 | 119 | 119 | 0.0% |
| 6.000% Notes due January 2056 | 735 | — | — |
| 6.125% Notes due November 2041 | 484 | 485 | -0.2% |
| 6.150% Notes due November 2036 | 190 | 190 | 0.0% |
| 7.875% Debentures due May 2027 | 260 | 259 | +0.4% |
| Step Down Notes due January 2033 | 45 | 45 | 0.0% |
| Other Liabilities | |||
| Pharmacy And Service Costs Payable (Q) | — | — | — |
Show — breakouts |
|||
| Pharmacy And Service Costs Payable | 30,333 | 28,465 | +6.6% |
| Accrued Expenses And Other Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Accrued Expenses And Other Liabilities | 9,048 | 9,387 | -3.6% |
| Long Term Debt And Capital Lease Obligations (Q) | — | — | — |
Show — breakouts |
|||
| Long Term Debt And Capital Lease Obligations | 30,871 | 28,937 | +6.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 30,268 | 28,134 | +7.6% |
| Separate Accounts Liability (Q) | — | — | — |
Show — breakouts |
|||
| Separate Accounts Liability | 7,511 | 7,278 | +3.2% |
| Stockholders' Equity | |||
| Common Stock (Q) | — | — | — |
Show — breakouts |
|||
| Common Stock | 4 | 4 | 0.0% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 4 | 4 | 0.0% |
| Additional Paid In Capital Common Stock (Q) | — | — | — |
Show — breakouts |
|||
| Additional Paid In Capital Common Stock | 31,790 | 31,288 | +1.6% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 31,790 | 31,288 | +1.6% |
| Accumulated Other Comprehensive Income (Q) | — | — | — |
Show — breakouts |
|||
| Accumulated Other Comprehensive Income | -2,806 | -2,341 | -19.9% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -2,806 | -2,341 | -19.9% |
Show Schedule Of Equity Method Investment Equity Method Investee Name breakouts |
|||
| Joint venture in China | -1,672 | -979 | -70.8% |
| Retained Earnings (Q) | — | — | — |
Show — breakouts |
|||
| Retained Earnings | 47,865 | 43,519 | +10.0% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 47,865 | 43,519 | +10.0% |
| Treasury Stock Value (Q) | — | — | — |
Show — breakouts |
|||
| Treasury Stock Value | -35,140 | -31,437 | -11.8% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -35,140 | -31,437 | -11.8% |
| Total Stockholders' Equity (Q) | — | — | — |
Show — breakouts |
|||
| Total Stockholders' Equity | 41,713 | 41,033 | +1.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 41,713 | 41,033 | +1.7% |
| Minority Interest (Q) | — | — | — |
Show — breakouts |
|||
| Minority Interest | 161 | 210 | -23.3% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest (Q) | — | — | — |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | -944 | -937 | -0.7% |
| Accumulated Other Comprehensive Income | -2,806 | -2,341 | -19.9% |
| Accumulated Translation Adjustment | -127 | -198 | +35.9% |
| Additional Paid In Capital | 31,790 | 31,288 | +1.6% |
| Common Stock | 4 | 4 | 0.0% |
| Net long-duration insurance and contractholder liabilities measurement adjustments | -2,329 | -2,038 | -14.3% |
| Noncontrolling Interest | 161 | 210 | -23.3% |
| Parent | 41,713 | 41,033 | +1.7% |
| Retained Earnings | 47,865 | 43,519 | +10.0% |
| Securities and derivatives | 594 | 832 | -28.6% |
| Treasury Stock Common | -35,140 | -31,437 | -11.8% |
Show — breakouts |
|||
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 41,874 | 41,243 | +1.5% |
| Total Liabilities & Equity (Q) | — | — | — |
Show — breakouts |
|||
| Total Liabilities & Equity | 157,919 | 155,881 | +1.3% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 75,723 | 73,771 | +2.6% |
Cash Flow Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization (FY) | — | — | — |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 16 | 9 | +77.8% |
| Cigna Healthcare · Operating Segments | 339 | 417 | -18.7% |
| Evernorth Health Services · Operating Segments | 2,400 | 2,319 | +3.5% |
Show — breakouts |
|||
| Depreciation & Amortization | 2,775 | 2,775 | 0.0% |
Show Depreciation And Amortization By Type [Axis] breakouts |
|||
| Other Intangible Assets | 1,549 | 1,506 | +2.9% |
| Other property and equipment | 239 | 248 | -3.6% |
| Software And Software Development Costs | 987 | 1,021 | -3.3% |
Show Consolidation Items breakouts |
|||
| Corporate and Eliminations | 20 | 30 | -33.3% |
| Increase Decrease In Deferred Income Taxes (FY) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Deferred Income Taxes | 326 | -95 | +443.2% |
| Increase Decrease In Accounts And Other Receivables (FY) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Accounts And Other Receivables | -4,630 | -7,369 | +37.2% |
| Change in Inventory (FY) | — | — | — |
Show — breakouts |
|||
| Change in Inventory | -646 | -1,032 | +37.4% |
| Increase Decrease In Reinsurance Recoverable (FY) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Reinsurance Recoverable | -897 | -485 | -84.9% |
| Increase Decrease In Insurance Liabilities (FY) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Insurance Liabilities | 1,247 | -591 | +311.0% |
| Increase Decrease In Pharmacy And Service Costs Payable (FY) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Pharmacy And Service Costs Payable | 1,868 | 8,757 | -78.7% |
| Increase Decrease In Accounts Payable Accrued And Other Operating Liabilities (FY) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Accounts Payable Accrued And Other Operating Liabilities | 2,797 | 1,138 | +145.8% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 496 | -306 | +262.1% |
| Increase Decrease In Other Operating Capital Net (FY) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Other Operating Capital Net | 462 | 774 | -40.3% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 592 | 243 | +143.6% |
| Net Cash from Operations (FY) | — | — | — |
Show — breakouts |
|||
| Net Cash from Operations | 9,601 | 10,363 | -7.4% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 1,580 | 2,133 | -25.9% |
| Deferred Income Taxes (FY) | — | — | — |
Show — breakouts |
|||
| Deferred Income Taxes | 326 | -95 | +443.2% |
| Investing Activities | |||
| Proceeds From Sale Of Debt And Equity Securities (FY) | — | — | — |
Show — breakouts |
|||
| Proceeds From Sale Of Debt And Equity Securities | 782 | 856 | -8.6% |
| Proceeds From Maturities Prepayments And Calls Of Debt And Equity Securities (FY) | — | — | — |
Show — breakouts |
|||
| Proceeds From Maturities Prepayments And Calls Of Debt And Equity Securities | 986 | 839 | +17.5% |
| Proceeds From Collection Of Loans Receivable (FY) | — | — | — |
Show — breakouts |
|||
| Proceeds From Collection Of Loans Receivable | 223 | 188 | +18.6% |
| Proceeds From Sale And Maturity Of Other Investments (FY) | — | — | — |
Show — breakouts |
|||
| Proceeds From Sale And Maturity Of Other Investments | 884 | 752 | +17.6% |
| Payments To Acquire Debt And Equity Securities (FY) | — | — | — |
Show — breakouts |
|||
| Payments To Acquire Debt And Equity Securities | -5,788 | -1,386 | -317.6% |
| Payments To Acquire Mortgage Notes Receivable (FY) | — | — | — |
Show — breakouts |
|||
| Payments To Acquire Mortgage Notes Receivable | -117 | -54 | -116.7% |
| Payments To Acquire Other Investments (FY) | — | — | — |
Show — breakouts |
|||
| Payments To Acquire Other Investments | -1,416 | -1,309 | -8.2% |
| Payments For Proceeds From Property Plant And Equipment (FY) | — | — | — |
Show — breakouts |
|||
| Payments For Proceeds From Property Plant And Equipment | -1,212 | -1,406 | +13.8% |
| Payments To Acquire Businesses Net Of Cash Acquired (FY) | — | — | — |
Show — breakouts |
|||
| Payments To Acquire Businesses Net Of Cash Acquired | -597 | -131 | -355.7% |
| Proceeds From Divestiture Of Businesses Net Of Cash Divested (FY) | — | — | — |
Show — breakouts |
|||
| Proceeds From Divestiture Of Businesses Net Of Cash Divested | 2,984 | 521 | +472.7% |
| Payments To Acquire Equity Method Investments (FY) | — | — | — |
Show — breakouts |
|||
| Payments To Acquire Equity Method Investments | -1,102 | -1,030 | -7.0% |
| Other Investing Activities (FY) | — | — | — |
Show — breakouts |
|||
| Other Investing Activities | -34 | 58 | -158.6% |
| Net Cash from Investing (FY) | — | — | — |
Show — breakouts |
|||
| Net Cash from Investing | -4,407 | -2,102 | -109.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 4,891 | — | — |
| Financing Activities | |||
| Additions To Contract Holders Funds (FY) | — | — | — |
Show — breakouts |
|||
| Additions To Contract Holders Funds | 152 | 166 | -8.4% |
| Withdrawal From Contract Holders Funds (FY) | — | — | — |
Show — breakouts |
|||
| Withdrawal From Contract Holders Funds | -253 | -228 | -11.0% |
| Proceeds From Repayments Of Other Short Term Debt (FY) | — | — | — |
Show — breakouts |
|||
| Proceeds From Repayments Of Other Short Term Debt | -927 | -402 | -130.6% |
| Proceeds From Notes Payable (FY) | — | — | — |
Show — breakouts |
|||
| Proceeds From Notes Payable | 1,999 | — | — |
Show Consolidated Entities breakouts |
|||
| Parent Company | 1,999 | — | — |
| Repayments Of Notes Payable (FY) | — | — | — |
Show — breakouts |
|||
| Repayments Of Notes Payable | -2,000 | — | — |
Show Consolidated Entities breakouts |
|||
| Parent Company | 2,000 | — | — |
| Repayments Of Long Term Debt (FY) | — | — | — |
Show — breakouts |
|||
| Repayments Of Long Term Debt | -4,197 | -3,000 | -39.9% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -3,861 | -2,731 | -41.4% |
| Proceeds From Issuance Of Long Term Debt (FY) | — | — | — |
Show — breakouts |
|||
| Proceeds From Issuance Of Long Term Debt | 4,458 | 4,462 | -0.1% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 4,458 | 4,462 | -0.1% |
| Share Repurchases (FY) | — | — | — |
Show — breakouts |
|||
| Share Repurchases | -3,621 | -7,034 | +48.5% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -3,621 | -7,034 | +48.5% |
| Proceeds From Issuance Of Common Stock (FY) | — | — | — |
Show — breakouts |
|||
| Proceeds From Issuance Of Common Stock | 203 | 305 | -33.4% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 203 | 305 | -33.4% |
| Payments Of Dividends Common Stock (FY) | — | — | — |
Show — breakouts |
|||
| Payments Of Dividends Common Stock | -1,611 | -1,567 | -2.8% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -1,611 | -1,567 | -2.8% |
| Proceeds From Payments For Other Financing Activities (FY) | — | — | — |
Show — breakouts |
|||
| Proceeds From Payments For Other Financing Activities | -624 | -349 | -78.8% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -108 | -117 | +7.7% |
| Net Cash from Financing (FY) | — | — | — |
Show — breakouts |
|||
| Net Cash from Financing | -6,421 | -7,647 | +16.0% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -6,522 | -2,278 | -186.3% |
| Supplemental | |||
| Interest Paid (FY) | — | — | — |
Show — breakouts |
|||
| Interest Paid | 1,350 | 1,342 | +0.6% |
| Income Taxes Paid (FY) | — | — | — |
Show — breakouts |
|||
| Income Taxes Paid | 399 | 898 | -55.6% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations (FY) | — | — | — |
Show — breakouts |
|||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 32 | -20 | +260.0% |
| Net Change in Cash (FY) | — | — | — |
Show — breakouts |
|||
| Net Change in Cash | -1,195 | 594 | -301.2% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -51 | -145 | +64.8% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations (Q) | — | — | — |
Show — breakouts |
|||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 7,736 | 8,931 | -13.4% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents (Q) | — | — | — |
Show — breakouts |
|||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 7,736 | 7,592 | +1.9% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 139 | 190 | -26.8% |
Values in millions USD. Source: SEC EDGAR 10-K filing.